Related Experiment Videos
Beta-endorphin effects on membrane transduction in human lymphocytes
F Chiappelli1, A Kavelaars, C J Heijnen
1Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles 90509.
Annals of the New York Academy of Sciences
|April 15, 1992
Summary
Beta-endorphin (beta E) has mixed effects on lymphocyte functions by modulating membrane signaling pathways. Its impact on cell immunity depends on dose and donor lymphocyte status.
Area of Science:
- Immunology
- Neuroendocrinology
- Cellular Signaling
Background:
- Endogenous opioid beta-endorphin (beta E) exhibits variable effects on lymphocyte cytotoxic and proliferative responses.
- Understanding the mechanisms behind beta E's modulation of lymphocyte function is crucial for its therapeutic potential.
Purpose of the Study:
- To investigate the specific membrane transduction events influenced by beta E in lymphocytes.
- To elucidate the molecular mechanisms underlying the diverse effects of beta E on cellular immunity.
Main Methods:
- Examined the impact of beta E on phosphoinositol phosphate metabolism in lymphocytes.
- Assessed the dose-dependent effects of beta E on the phosphorylation of the CD3 gamma chain.
Main Results:
- Beta-endorphin was found to inhibit phosphoinositol phosphate metabolism.
- Beta-endorphin demonstrated a dose-dependent ability to either enhance or inhibit CD3 gamma chain phosphorylation.
- Lymphocyte biochemical status influenced beta E's effects on cell-mediated immunity (CMI).
Conclusions:
- Beta-endorphin likely modulates multiple, potentially counteracting, membrane transduction processes simultaneously.
- The observed mixed effects of beta E on lymphocyte functions are explained by the interplay of these signaling pathways.
- Donor lymphocyte characteristics contribute to the variability in beta E-mediated CMI outcomes.